INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,992,000 | +11.1% | 76,281 | -20.8% | 0.51% | +0.4% |
Q3 2021 | $3,592,000 | +8.6% | 96,358 | +18.9% | 0.51% | +15.1% |
Q2 2021 | $3,308,000 | +5.4% | 81,031 | -12.4% | 0.44% | +3.0% |
Q1 2021 | $3,139,000 | -26.8% | 92,504 | -31.4% | 0.43% | -30.5% |
Q4 2020 | $4,290,000 | -27.4% | 134,891 | -41.4% | 0.62% | -32.6% |
Q3 2020 | $5,907,000 | -14.8% | 230,203 | -14.8% | 0.92% | -18.4% |
Q2 2020 | $6,937,000 | +158.5% | 270,219 | +54.8% | 1.13% | +130.8% |
Q1 2020 | $2,684,000 | -23.2% | 174,594 | +71.4% | 0.49% | +3.4% |
Q4 2019 | $3,496,000 | -55.1% | 101,889 | -83.0% | 0.47% | -57.3% |
Q2 2019 | $7,791,000 | +80.9% | 600,236 | +69.8% | 1.11% | +89.6% |
Q1 2019 | $4,307,000 | +15.6% | 353,592 | +8.1% | 0.59% | +4.1% |
Q4 2018 | $3,727,000 | -16.0% | 327,226 | +60.0% | 0.56% | -5.7% |
Q3 2018 | $4,437,000 | +40.6% | 204,470 | +14.5% | 0.60% | +33.6% |
Q2 2018 | $3,156,000 | +41.2% | 178,590 | +68.2% | 0.45% | +45.1% |
Q1 2018 | $2,235,000 | -17.5% | 106,182 | -43.3% | 0.31% | -8.9% |
Q4 2017 | $2,709,000 | -7.1% | 187,120 | +1.2% | 0.34% | -5.1% |
Q3 2017 | $2,917,000 | +50.2% | 184,836 | +18.2% | 0.36% | +49.0% |
Q2 2017 | $1,942,000 | +16.8% | 156,349 | +52.8% | 0.24% | +17.7% |
Q1 2017 | $1,663,000 | – | 102,326 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |